Laura Hou, MA, MPH

Harvard Pilgrim Healthcare Institute

Poster(s):

• (B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-316) Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET